Rectal cancer

2022 - 8 - 7

Ask the Doctors: Promising study on rectal cancer has narrow scope (Tulsa World)

Dear Doctors: I saw on the evening news that some doctors in New York City actually cured rectal cancer with a new drug. My dad has rectal cancer, and when.

The patients in the study will now undergo several years of follow-up and observation. Researchers were startled when no trace of cancer was detected in any of the 12 study participants. When a tumor is located close to the rectum, surgery to remove it will leave the patient dependent on a colostomy bag. Known as dostarlimab, itโ€™s fairly new, having been approved by the FDA for use as a cancer treatment in early 2021. Youโ€™re correct that this research was conducted by doctors at Memorial Sloan Kettering Cancer Center in New York City. And while itโ€™s also correct that the study focused on rectal cancer, the scope was actually quite narrow. Their tumors also shared a certain kind of genetic anomaly that appears in fewer than 10% of patients and makes this subset of rectal cancer difficult to treat.

Explore the last week